HealthQuill Kidneys
Swedish-British AstraZeneca Plc’s medicine baxdrostat lowered blood pressure in trial patients during an end-stage study, and the company plans to file for regulatory approvals by the end of the year.
Drugs Health Pharma

AstraZeneca’s medicine lowers BP, to file for early approvals

Swedish-British AstraZeneca Plc’s medicine baxdrostat lowered blood pressure in trial patients during an end-stage study, and the company plans to file for regulatory.

Read More
AstraZeneca Plc’s investigational drug to treat AL amyloidosis, a rare and serious disease affecting the heart and kidneys, failed to meet its main goal of helping people to live longer.
Drugs Health Pharma

AstraZeneca’s trial drug for AL amyloidosis fails to meet survival goal

HQ Team July 16, 2025: AstraZeneca Plc’s investigational drug to treat AL amyloidosis, a rare and serious disease affecting the heart and kidneys,.

Read More
Rats living in urban areas spread a deadly disease called Leptospirosis as they migrate within the cities, according to Tufts University researchers, who also discovered a method to test the kidneys of the mammals.
Climate Health Research

Rats in urban areas spread Leptospirosis as they migrate: Tufts study

HQ Team May 6, 2025: Rats living in urban areas spread a deadly disease called Leptospirosis as they migrate within the cities, according.

Read More